Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
A double-blind, randomized, placebo-controlled, parallel-group study of THC/CBD oromucosal spray in combination with the existing treatment regimen, in the relief of central neuropathic pain in patients with multiple sclerosis.
Acid-sensing ion channels: trafficking and synaptic function.
Decreased signal transducers and activators of transcription (STAT) protein expression in lymphatic organs during EAE development in mice.
Low Dose Naltrexone for Treatment of Multiple Sclerosis: A Retrospective Chart Review of Safety and Tolerability.
Vitamin D and multiple sclerosis: where do we go from here?
A novel anti-EMMPRIN function-blocking antibody reduces T cell proliferation and neurotoxicity: relevance to multiple sclerosis.
Long-Term Decrease in VLA-4 Expression and Functional Impairment of Dendritic Cells during Natalizumab Therapy in Patients with Multiple Sclerosis.
Increase in the prevalence of multiple sclerosis over a 17-year period in Osona, Catalonia, Spain.
Diffusion tensor imaging based network analysis detects alterations of neuroconnectivity in patients with clinically early relapsing-remitting multiple sclerosis.
Ibuprofen-induced unilateral optic neuritis.
Role of Platelets in Neurodegenerative Diseases: A Universal Pathophysiology.
Multiple sclerosis and glutamate excitotoxicity.
Association between a Genetic Variant of Type-1 Cannabinoid Receptor and Inflammatory Neurodegeneration in Multiple Sclerosis.
Immune activation, viral gene product expression and neurotoxicity in the HIV-1 transgenic rat.
Endogenous opioids regulate expression of experimental autoimmune encephalomyelitis: a new paradigm for the treatment of multiple sclerosis.
Delta-9-tetrahydrocannabinol shows antispastic and analgesic effects in a single case double-blind trial.
RORγt-specific transcriptional interactomic inhibition suppresses autoimmunity associated with TH17 cells.
Immunomodulation of fucosyl-lactose and lacto-N-fucopentaose on mononuclear cells from multiple sclerosis and healthy subjects.
Fingolimod-Associated Peripheral Vascular Adverse Effects.
Upregulation of integrin expression on monocytes in multiple sclerosis patients treated with natalizumab.
Riluzole specifically blocks inactivated Na channels in myelinated nerve fibre.
Stress as a risk factor for multiple sclerosis onset or relapse: a systematic review.
Resveratrol effects on astrocyte function: Relevance to neurodegenerative diseases.
Management of multiple sclerosis during pregnancy and the reproductive years: a systematic review.
The origins of multiple sclerosis: a synthesis
Pages
« first
‹ previous
…
175
176
177
178
179
180
181
182
183
…
next ›
last »